HSCSW — Heart Test Laboratories Inc. Warrant

Heart Test Laboratories Inc. Warrant (HSCSW) is a medical devices company listed on NASDAQ. It is led by Andrew Simpson, based in 550 Reserve Street, Southlake, TX, United States, 76092, with about 15 employees. HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Latest reported HSCSW revenue for 2025-07-31 was $1.9K. Net income was -$2.1M. Revenue was down 56.3% from 2025-04-30 to 2025-07-31.

Use this HSCSW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the HSCSW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the HSCSW SEC filings page. Lician reads the product cache first so this HTML stays unique to Heart Test Laboratories Inc. Warrant even when a live quote feed is slow.